Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.260
-0.060 (-4.55%)
At close: Nov 20, 2024, 4:00 PM
1.310
+0.050 (3.97%)
Pre-market: Nov 21, 2024, 7:00 AM EST
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,070,295
Market Cap
2.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Regional Health Properties | 114 |
Fresh2 Group | 75 |
Molecular Templates | 62 |
Nuwellis | 59 |
Matinas BioPharma Holdings | 32 |
Scinai Immunotherapeutics | 31 |
ReShape Lifesciences | 29 |
ENDRA Life Sciences | 21 |
BBLG News
- 4 weeks ago - Bone Biologics Appoints Phillip T. Meikle to its Board of Directors - Business Wire
- 2 months ago - Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
- 3 months ago - Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds - Business Wire
- 5 months ago - First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion - Business Wire
- 9 months ago - Bone Biologics Announces Closing of $2.0 Million Public Offering - Business Wire
- 9 months ago - Bone Biologics Announces Pricing of $2.0 Million Public Offering - Business Wire
- 9 months ago - Bone Biologics Reports Progress With NB1 Clinical Program - Business Wire
- 11 months ago - Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors - Business Wire